| The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis ES Orwoll, WH Scheele, S Paul, S Adami, U Syversen, A Diez‐Perez, ... Journal of bone and mineral research 18 (1), 9-17, 2003 | 874 | 2003 |
| Adiponectin and its receptors are expressed in bone-forming cells HS Berner, SP Lyngstadaas, A Spahr, M Monjo, L Thommesen, ... Bone 35 (4), 842-849, 2004 | 628 | 2004 |
| Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling JO Gordeladze, CA Drevon, U Syversen, JE Reseland Journal of cellular biochemistry 85 (4), 825-836, 2002 | 530 | 2002 |
| Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization JE Reseland, U Syversen, I Bakke, G Qvigstad, LG Eide, Ø Hjertner, ... Journal of Bone and Mineral Research 16 (8), 1426-1433, 2001 | 497 | 2001 |
| Two‐year results of once‐weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis Alendronate Once‐Weekly Study Group, R Rizzoli Journal of Bone and Mineral Research 17 (11), 1988-1996, 2002 | 300 | 2002 |
| Long-term serotonin administration induces heart valve disease in rats BI Gustafsson, K Tømmerås, I Nordrum, JP Loennechen, A Brunsvik, ... Circulation 111 (12), 1517-1522, 2005 | 266 | 2005 |
| Marked increase in gastric acid secretory capacity after omeprazole treatment. HL Waldum, JS Arnestad, E Brenna, I Eide, U Syversen, AK Sandvik Gut 39 (5), 649-653, 1996 | 259 | 1996 |
| Sustained nonvertebral fragility fracture risk reduction after discontinuation of teriparatide treatment R Prince, A Sipos, A Hossain, U Syversen, S Ish‐Shalom, E Marcinowska, ... Journal of Bone and Mineral Research 20 (9), 1507-1513, 2005 | 234 | 2005 |
| Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism L Thommesen, AK Stunes, M Monjo, K Grøsvik, MV Tamburstuen, E Kjøbli, ... Journal of cellular biochemistry 99 (3), 824-834, 2006 | 217 | 2006 |
| Serotonin and fluoxetine modulate bone cell function in vitro BI Gustafsson, L Thommesen, AK Stunes, K Tommeras, I Westbroek, ... Journal of cellular biochemistry 98 (1), 139-151, 2006 | 185 | 2006 |
| Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone K Lovas, CG Gjesdal, M Christensen, AB Wolff, B Almas, J Svartberg, ... European Journal of Endocrinology 160 (6), 993, 2009 | 163 | 2009 |
| The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report S Boonen, R Rizzoli, PJ Meunier, M Stone, G Nuki, U Syversen, ... Osteoporosis international 15 (7), 511-519, 2004 | 147 | 2004 |
| Long-term effects of inhaled nicotine HL Waldum, OG Nilsen, T Nilsen, H Rørvik, U Syversen, AK Sandvik, ... Life sciences 58 (16), 1339-1346, 1996 | 140 | 1996 |
| Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings? A Angelsen, U Syversen, OA Haugen, M Stridsberg, OK Mjølnerød, ... The Prostate 30 (1), 1-6, 1997 | 138 | 1997 |
| Neuroendocrine differentiation in human gastric carcinoma HL Waldum, S Aase, I Kvetnoi, E Brenna, AK Sandvik, U Syversen, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 136 | 1998 |
| Sub‐micron spongiform porosity is the major ultra‐structural alteration occurring in archaeological bone G Turner‐Walker, CM Nielsen‐Marsh, U Syversen, H Kars, MJ Collins International Journal of Osteoarchaeology 12 (6), 407-414, 2002 | 114 | 2002 |
| Quantifying histological changes in archaeological bones using BSE–SEM image analysis G Turner–Walker, U Syversen Archaeometry 44 (3), 461-468, 2002 | 105 | 2002 |
| Maximal strength training in postmenopausal women with osteoporosis or osteopenia MP Mosti, N Kaehler, AK Stunes, J Hoff, U Syversen The Journal of Strength & Conditioning Research 27 (10), 2879-2886, 2013 | 103 | 2013 |
| The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas G Aune, AK Stunes, S Tingulstad, Ø Salvesen, U Syversen, SH Torp International journal of clinical and experimental pathology 4 (5), 444, 2011 | 93 | 2011 |
| Different skeletal effects of the peroxisome proliferator activated receptor (PPAR) α agonist fenofibrate and the PPARγ agonist pioglitazone U Syversen, AK Stunes, BI Gustafsson, KJ Obrant, L Nordsletten, R Berge, ... BMC endocrine disorders 9 (1), 1-13, 2009 | 92 | 2009 |
Janne E ReselandProfessor Department of Biomaterials, University of OsloVerifisert e-postadresse på odont.uio.no
